StockDriftsStockDriftsTelcon RF Pharmaceutical (200230) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Telcon RF Pharmaceutical is dated 2024-12-12; the most recent is 2026-07-15. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-07-15 | BUY | 유상신주취득 | 에버코어인베스트먼트홀딩스 Evercore Investment Holdings | - | 2.3M | ₩2,170 | +3.7% | ₩5.0B ($3.5M) |
| 2026-07-10 | SELL | 장외매도 | 뉴온 newon | - | -660.0K | ₩2,135 | -5.4% | ₩1.4B ($960K) |
| 2026-07-10 | BUY | 장외매수 | 에버코어인베스트먼트홀딩스 Evercore Investment Holdings | - | 660.0K | ₩2,135 | +5.4% | ₩1.4B ($960K) |
| 2026-06-06 | SELL | 자본감소 | 뉴온 newon | - | -12.4M | - | - | - |
| 2026-04-17 | BUY | 유상신주취득 | 뉴온 newon | - | 3.0M | ₩712 | -6.9% | ₩2.1B ($1.5M) |
| 2025-09-15 | BUY | 무상신주취득 | 뉴온 newon | - | 7.2M | ₩1,332 | -38.4% | ₩9.5B ($6.6M) |
| 2025-08-20 | BUY | 유상신주취득 | 뉴온 newon | - | 1.1M | ₩1,830 | -55.2% | ₩2.0B ($1.4M) |
| 2025-08-12 | SELL | 기타 | 뉴온 newon | - | -1.1M | ₩1,763 | +53.5% | ₩2.0B ($1.4M) |
| 2025-07-24 | SELL | 기타 | 뉴온 newon | - | -1.1M | ₩1,886 | +56.5% | ₩2.1B ($1.5M) |
| 2025-07-17 | BUY | 기타 | 뉴온 newon | - | 2.2M | ₩2,273 | -63.9% | ₩5.1B ($3.5M) |
| 2024-12-12 | SELL | 주식병합 | 뉴온 newon | - | -22.2M | ₩1,612 | +49.1% | ₩35.8B ($24.9M) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Telcon RF Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.